Víctor E. Márquez

21.2k total citations
412 papers, 16.6k citations indexed

About

Víctor E. Márquez is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Víctor E. Márquez has authored 412 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 312 papers in Molecular Biology, 108 papers in Organic Chemistry and 96 papers in Infectious Diseases. Recurrent topics in Víctor E. Márquez's work include HIV/AIDS drug development and treatment (93 papers), Biochemical and Molecular Research (79 papers) and Epigenetics and DNA Methylation (65 papers). Víctor E. Márquez is often cited by papers focused on HIV/AIDS drug development and treatment (93 papers), Biochemical and Molecular Research (79 papers) and Epigenetics and DNA Methylation (65 papers). Víctor E. Márquez collaborates with scholars based in United States, South Korea and Israel. Víctor E. Márquez's co-authors include Peter M. Blumberg, James A. Kelley, M. Arshad Siddiqui, Mu‐Ill Lim, John S. Driscoll, Joseph J. Barchi, Peter A. Jones, Marc C. Nicklaus, Christopher K. H. Tseng and Nancy E. Lewin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Víctor E. Márquez

409 papers receiving 16.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Víctor E. Márquez 12.2k 2.8k 2.4k 1.8k 1.7k 412 16.6k
Antonello Mai 9.0k 0.7× 2.2k 0.8× 1.2k 0.5× 1.8k 1.0× 1.8k 1.1× 393 14.2k
Jun O. Liu 8.9k 0.7× 1.3k 0.5× 721 0.3× 2.7k 1.5× 1.4k 0.8× 210 14.2k
Herman S. Overkleeft 14.8k 1.2× 10.5k 3.7× 775 0.3× 2.8k 1.5× 2.1k 1.2× 668 22.3k
Alan C. Sartorelli 8.5k 0.7× 3.1k 1.1× 726 0.3× 4.9k 2.7× 807 0.5× 514 15.9k
Takashi Tsuruo 16.6k 1.4× 1.7k 0.6× 1.3k 0.6× 12.4k 6.8× 1.3k 0.8× 446 27.7k
Anna Karlsson 3.7k 0.3× 1.2k 0.4× 2.3k 1.0× 710 0.4× 1.0k 0.6× 186 7.1k
Paul A. Marks 17.9k 1.5× 1.4k 0.5× 351 0.1× 4.6k 2.5× 1.1k 0.6× 202 22.6k
Ricky W. Johnstone 18.7k 1.5× 1.2k 0.4× 650 0.3× 7.8k 4.3× 1.8k 1.0× 248 25.4k
Maria Castedo 11.9k 1.0× 787 0.3× 431 0.2× 4.9k 2.7× 2.1k 1.2× 108 19.0k
Victoria M. Richon 20.3k 1.7× 1.3k 0.5× 343 0.1× 5.2k 2.8× 736 0.4× 123 23.0k

Countries citing papers authored by Víctor E. Márquez

Since Specialization
Citations

This map shows the geographic impact of Víctor E. Márquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor E. Márquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor E. Márquez more than expected).

Fields of papers citing papers by Víctor E. Márquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor E. Márquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor E. Márquez. The network helps show where Víctor E. Márquez may publish in the future.

Co-authorship network of co-authors of Víctor E. Márquez

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor E. Márquez. A scholar is included among the top collaborators of Víctor E. Márquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor E. Márquez. Víctor E. Márquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Márquez, Víctor E., et al.. (2025). Developing personalized brain state-dependent TMS to target residual corticospinal connections after stroke. Brain stimulation. 18(1). 272–272.
2.
Nagarsheth, Nisha, Dongjun Peng, Ilona Kryczek, et al.. (2015). PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Research. 76(2). 275–282. 213 indexed citations
3.
Fulkerson, Christopher M., Deepika Dhawan, D. I. Jones, et al.. (2015). Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs. Veterinary and Comparative Oncology. 15(1). 226–236. 7 indexed citations
4.
Avan, Amir, Francesco Crea, Elisa Paolicchi, et al.. (2012). Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 11(8). 1735–1746. 80 indexed citations
5.
Fiskus, Warren, Rekha Rao, Ramesh Balusu, et al.. (2012). Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells. Clinical Cancer Research. 18(22). 6227–6238. 40 indexed citations
6.
Ren, Shun X., Alfred S.L. Cheng, Ka‐Fai To, et al.. (2012). Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer. Cancer Research. 72(24). 6512–6523. 115 indexed citations
7.
Márquez, Víctor E., et al.. (2012). Hypermethylated in cancer 1 (HIC1), a tumour suppressor gene epigenetically deregulated in hyperparathyroid tumours by histone modification. 15th International & 14th European Congress of Endocrinology. 29. 4 indexed citations
8.
Sandovici, Ionel, Noel H. Smith, Marloes Dekker Nitert, et al.. (2011). Maternal diet and aging alter the epigenetic control of a promoter–enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proceedings of the National Academy of Sciences. 108(13). 5449–5454. 247 indexed citations
9.
Wang, Chunxi, Zhihui Liu, Zhijie Li, et al.. (2011). EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1 , CLU , RUNX3 , and NGFR. Cancer Research. 72(1). 315–324. 140 indexed citations
10.
Rao, Mahadev, Nachimuthu Chinnasamy, Julie A. Hong, et al.. (2011). Inhibition of Histone Lysine Methylation Enhances Cancer–Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer. Cancer Research. 71(12). 4192–4204. 90 indexed citations
11.
Kemp, Clinton D., Mahadev Rao, Sichuan Xi, et al.. (2011). Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy. Clinical Cancer Research. 18(1). 77–90. 77 indexed citations
12.
Chen, Min, Akbar Nawab, Sherry X. Yang, et al.. (2011). DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer. Molecular Cancer Therapeutics. 11(2). 370–382. 47 indexed citations
13.
Kim, Rachel, Ziwei Li, Víctor E. Márquez, et al.. (2011). Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatin. Human Molecular Genetics. 21(4). 751–764. 46 indexed citations
14.
Miranda, Tina Branscombe, Connie C. Cortez, Christine B. Yoo, et al.. (2009). DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Molecular Cancer Therapeutics. 8(6). 1579–1588. 473 indexed citations
15.
Sun, Feng, Eli Chan, Zhenlong Wu, et al.. (2009). Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. Molecular Cancer Therapeutics. 8(12). 3191–3202. 63 indexed citations
16.
Suvà, Mario-Luca, Nicolò Riggi, Michalina Janiszewska, et al.. (2009). EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance. Cancer Research. 69(24). 9211–9218. 379 indexed citations
17.
Yoo, Christine B., Jody C. Chuang, Hyang‐Min Byun, et al.. (2008). Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice. Cancer Prevention Research. 1(4). 233–240. 70 indexed citations
18.
Wu, Zhengrong, et al.. (2004). Changes in DNA bending induced by restricting nucleotide ring pucker studied by weak alignment NMR spectroscopy. Proceedings of the National Academy of Sciences. 102(1). 24–28. 20 indexed citations
19.
Lee, Jeewoo, Jeewoo Lee, Jiyoun Lee, et al.. (2001). N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics. Bioorganic & Medicinal Chemistry. 9(1). 19–32. 42 indexed citations
20.
Márquez, Víctor E., et al.. (1995). Synthesis and Biological Activity of Sugar-Fluorinated 2′,3′-dideoxy-4′-thioribofuranosyl Nucleosides. Nucleosides and Nucleotides. 14(3-5). 555–558. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonello Mai Breakdown of academic impact, for papers by Jun O. Liu Breakdown of academic impact, for papers by Herman S. Overkleeft Breakdown of academic impact, for papers by Alan C. Sartorelli Breakdown of academic impact, for papers by Takashi Tsuruo Breakdown of academic impact, for papers by Anna Karlsson Breakdown of academic impact, for papers by Paul A. Marks Breakdown of academic impact, for papers by Ricky W. Johnstone Breakdown of academic impact, for papers by Maria Castedo Breakdown of academic impact, for papers by Victoria M. Richon
Rankless by CCL
2026